Addus HomeCare (NASDAQ:ADUS) Stock Price Expected to Rise, Stephens Analyst Says

Addus HomeCare (NASDAQ:ADUS) had its price target increased by research analysts at Stephens from $143.00 to $145.00 in a report released on Wednesday,Benzinga reports. The firm presently has an “overweight” rating on the stock. Stephens’ target price points to a potential upside of 12.33% from the stock’s previous close.

ADUS has been the topic of a number of other research reports. Oppenheimer upped their price objective on Addus HomeCare from $140.00 to $145.00 and gave the stock an “outperform” rating in a report on Monday, September 23rd. Macquarie reaffirmed an “outperform” rating and set a $139.00 price target on shares of Addus HomeCare in a research note on Monday. Royal Bank of Canada reduced their price objective on shares of Addus HomeCare from $141.00 to $136.00 and set an “outperform” rating for the company in a research note on Wednesday. TD Cowen upped their target price on shares of Addus HomeCare from $128.00 to $137.00 and gave the stock a “buy” rating in a research report on Thursday, August 8th. Finally, KeyCorp started coverage on shares of Addus HomeCare in a report on Friday, October 11th. They issued an “overweight” rating and a $150.00 target price for the company. One equities research analyst has rated the stock with a sell rating, eight have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat, Addus HomeCare has a consensus rating of “Moderate Buy” and a consensus target price of $131.63.

Addus HomeCare Stock Performance

ADUS stock opened at $129.08 on Wednesday. The stock has a market capitalization of $2.34 billion, a PE ratio of 29.54, a price-to-earnings-growth ratio of 2.33 and a beta of 1.04. The company has a fifty day moving average of $129.71 and a 200-day moving average of $120.97. Addus HomeCare has a one year low of $81.51 and a one year high of $136.12.

Addus HomeCare (NASDAQ:ADUS) last announced its quarterly earnings data on Monday, November 4th. The company reported $1.30 EPS for the quarter, beating analysts’ consensus estimates of $1.28 by $0.02. Addus HomeCare had a net margin of 6.50% and a return on equity of 10.12%. The firm had revenue of $289.80 million during the quarter, compared to the consensus estimate of $289.42 million. During the same quarter last year, the firm earned $1.03 earnings per share. The firm’s revenue was up 7.1% compared to the same quarter last year. Equities analysts forecast that Addus HomeCare will post 4.57 earnings per share for the current fiscal year.

Insider Activity at Addus HomeCare

In other Addus HomeCare news, Director Esteban Lopez sold 500 shares of the firm’s stock in a transaction on Tuesday, September 10th. The stock was sold at an average price of $127.50, for a total transaction of $63,750.00. Following the completion of the transaction, the director now owns 3,366 shares of the company’s stock, valued at approximately $429,165. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. In other Addus HomeCare news, EVP Michael D. Wattenbarger sold 21,917 shares of the company’s stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $133.29, for a total value of $2,921,316.93. Following the transaction, the executive vice president now directly owns 7,215 shares in the company, valued at approximately $961,687.35. This represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Esteban Lopez sold 500 shares of Addus HomeCare stock in a transaction dated Tuesday, September 10th. The stock was sold at an average price of $127.50, for a total transaction of $63,750.00. Following the sale, the director now owns 3,366 shares of the company’s stock, valued at approximately $429,165. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 22,917 shares of company stock valued at $3,050,082. 4.60% of the stock is owned by corporate insiders.

Institutional Trading of Addus HomeCare

Hedge funds have recently bought and sold shares of the company. UMB Bank n.a. raised its holdings in Addus HomeCare by 64.2% in the 2nd quarter. UMB Bank n.a. now owns 225 shares of the company’s stock valued at $26,000 after acquiring an additional 88 shares during the last quarter. Quest Partners LLC purchased a new stake in shares of Addus HomeCare in the second quarter valued at $31,000. EntryPoint Capital LLC acquired a new position in Addus HomeCare in the first quarter valued at $44,000. Innealta Capital LLC acquired a new position in Addus HomeCare in the second quarter valued at $44,000. Finally, Farther Finance Advisors LLC lifted its position in Addus HomeCare by 9,150.0% during the third quarter. Farther Finance Advisors LLC now owns 370 shares of the company’s stock worth $49,000 after buying an additional 366 shares during the period. Institutional investors and hedge funds own 95.35% of the company’s stock.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.